Lupus

Location: Huntington Beach

Stay: None

Gender: Male/Female

Ages: 18+

Compensation: $60 per visit + $240 for infusion visit

Smokers Allowed: Yes

Study Overview:

The primary objective of SL0023 is to assess the dose-response for the efficacy of iv DZP (3 dose groups) at Week 24 of the Double-Blind Treatment Period (Part 1) in adult subjects with moderately to severely active SLE receiving stable standard-of-care treatment.

Enroll In This Study